Bruker Corp. buy Guggenheim
Start price
24.02.25
/
50%
€50.02
Target price
24.02.26
-
Performance (%)
-33.15%
End price
25.02.26
€33.44
Summary
This prediction ended on 25.02.26 with a price of €33.44. Massive losses of -33.15% were the result for the BUY prediction by Guggenheim. Guggenheim has a follow-up prediction for Bruker Corp. where he still thinks Bruker Corp. is a Buy. Dividends of €0.20 are taken into consideration when calculating the performance. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bruker Corp. | 0.741% | 0.741% | 73.827% |
| iShares Core DAX® | 0.073% | 0.242% | 2.887% |
| iShares Nasdaq 100 | -1.344% | -3.371% | 29.208% |
| iShares Nikkei 225® | -2.314% | -7.496% | 56.323% |
| iShares S&P 500 | -0.340% | 0.899% | 23.175% |
Comments by Guggenheim for this prediction
In the thread Bruker Corp. diskutieren
Bruker Co. (NASDAQ: BRKR) had its "buy" rating re-affirmed by analysts at Guggenheim.
Ratings data for BRKR provided by MarketBeat
In the thread Trading Bruker Corp.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten